Ashburton, reported that he had taken Lamictal at the prescribed maintenance dose for several months after a gradual increase. His seizure diary showed fewer episodes by the later part of treatment, although dizziness during the first weeks made driving uncomfortable. He found that taking the tablet at the same time each day reduced missed doses.
Adults and children with epilepsy, or adults with bipolar I disorder needing long-term mood-episode prevention, may be prescribed Lamictal. Its active ingredient, lamotrigine, reduces excessive electrical signalling in the brain and supports seizure control and bipolar maintenance treatment.
Overview
Lamictal contains lamotrigine, a phenyltriazine anti-epileptic medication. Lamotrigine is used to control several seizure types and to delay new mood episodes in bipolar I disorder. Its clinical role is mainly preventive and maintenance-based rather than emergency treatment of an active seizure or acute manic episode.
Formulation
Lamictal contains lamotrigine, a phenyltriazine anti-epileptic medication. The active ingredient supports seizure control and maintenance treatment in bipolar I disorder.
Therapeutic indications
Lamictal is prescribed for epilepsy and for maintenance treatment in bipolar I disorder. The exact role depends on age, seizure pattern, other anti-epileptic medicines, previous treatment response and the person’s medical history.
| Clinical use | Therapeutic goal | Typical treatment role |
|---|---|---|
| Focal seizures | Reduce seizure frequency | Long-term seizure control |
| Generalised seizures, including those associated with Lennox-Gastaut syndrome | Limit abnormal electrical discharges | Long-term epilepsy treatment |
| Bipolar I disorder | Delay future depressive or mood episodes | Maintenance treatment |
Management of Epilepsy Subtypes
Lamotrigine may be used for focal seizures and several generalised seizure patterns. Lennox-Gastaut syndrome is a severe childhood epilepsy syndrome involving multiple seizure types and developmental difficulties; lamotrigine can form part of an individualised treatment plan for associated generalised seizures.
In clinical practice, seizure reduction is assessed over time rather than after one tablet. A seizure diary can help the prescriber distinguish treatment response from ordinary day-to-day variation. New seizure patterns, longer seizures or clusters of seizures need prompt medical assessment.
Lamictal does not replace an emergency seizure plan. A person who has a prolonged seizure, repeated seizures without recovery, breathing difficulty or injury requires urgent emergency care.
Mood Stabilisation in Bipolar Disorder
Lamotrigine is used to delay recurrence of mood episodes in bipolar I disorder, with a strong role in preventing depressive relapse. It does not provide the same acute anti-manic effect as medicines selected specifically for mania.
This distinction prevents a common misunderstanding. Feeling more stable after several weeks does not mean Lamictal should be stopped when mood improves. Maintenance treatment is intended to continue during stable periods when the prescriber considers it appropriate.
The New Zealand Medicines and Medical Devices Safety Authority, Medsafe, and the EMA describe lamotrigine as a medicine requiring indication-specific titration and monitoring [2].
Dosage and administration
Lamictal tablets are taken by mouth. The amount and frequency depend on the purpose of treatment and are agreed with a doctor or pharmacist. The schedule changes when lamotrigine is combined with medicines that speed up or slow down its metabolism.
- Take the medicine at the prescribed intervals.
- Increase the dose only according to the agreed titration schedule.
- Do not make up for a missed dose by taking extra tablets.
- If several doses are missed, contact the prescriber before restarting; the previous dose may no longer be appropriate.
- Do not stop suddenly unless urgent medical advice directs this.
- Tell every prescriber about sodium valproate, valproic acid, carbamazepine, primidone, oxcarbazepine and other anti-epileptic medicines.
Slow titration is used because rapid exposure to lamotrigine increases the risk of severe cutaneous adverse reactions. The starting schedule can also change when valproate is present, because valproate reduces lamotrigine clearance.
The tablet should be taken exactly as prescribed. If vomiting occurs soon after a dose, do not automatically repeat it; the appropriate action depends on timing and the treatment plan.
Reasons not to use it
Lamictal is not suitable for you if you have had a previous serious allergic reaction to lamotrigine or a severe lamotrigine-related skin reaction. A history of Stevens–Johnson syndrome, toxic epidermal necrolysis or drug-related hypersensitivity requires special caution and specialist review.
Medical review is needed before treatment when there is:
- Previous severe rash caused by an anti-epileptic medicine.
- Significant liver disease or kidney impairment.
- Current treatment with sodium valproate, valproic acid, carbamazepine, primidone or oxcarbazepine.
- Pregnancy, planned pregnancy or breastfeeding.
- A history of blood disorders or unexplained low blood counts.
- New depression, suicidal thoughts, severe agitation or unusual behavioural change.
Lamotrigine can also interact with hormonal contraceptives. Hormonal changes may affect lamotrigine exposure, and lamotrigine may alter contraceptive reliability in some circumstances. The contraceptive method and any changes in bleeding pattern should be reviewed with the prescriber.
When this is not for you
This medicine may not be right for you if you have previously had a serious rash or allergic reaction to lamotrigine or another anti-epileptic medicine. Speak with your prescriber before treatment if you have liver or kidney problems, blood disorders, are pregnant or breastfeeding, or take valproate, carbamazepine, primidone or oxcarbazepine. Get medical help urgently if you develop a new rash, swelling, breathing difficulty, severe mood changes or unusual bruising.
Possible side effects
Common adverse effects include headache, dizziness, nausea, blurred or double vision, sleepiness and coordination problems. These effects can be more noticeable during dose increases and may affect driving, cycling, climbing or work with machinery.
Some people experience tremor, insomnia, irritability or gastrointestinal discomfort. Alcohol can worsen dizziness and impaired coordination, making accidents more likely. A new visual disturbance should not be ignored, especially if it is accompanied by loss of balance or severe headache.
Serious Skin Reactions
A new rash during the early stages of treatment needs prompt medical attention. The risk is higher with rapid titration and with concomitant valproate. Stevens–Johnson syndrome and toxic epidermal necrolysis are rare but life-threatening reactions that can begin with flu-like symptoms before extensive skin or mucosal involvement appears.
Stop and seek urgent medical assessment for a rash with blistering, skin peeling, facial swelling, painful mouth or eye sores, fever, marked weakness or swollen lymph nodes. Do not restart lamotrigine after a suspected serious rash unless a specialist specifically directs this.
Other urgent reactions can include facial or throat swelling, breathing difficulty, severe blood abnormalities, liver injury, aseptic meningitis and severe hypersensitivity. The FDA prescribing information describes these warnings and the need for rapid assessment [3].
Practical Tolerability Points
Dizziness may be more troublesome when standing quickly. Rising slowly can reduce falls, but persistent or severe dizziness requires review.
Double vision can make driving unsafe even when the person feels otherwise alert. Work that involves ladders, heights or moving machinery should wait until vision and coordination are reliably normal.
How it affects the body
Lamotrigine blocks voltage-gated sodium channels in overactive neurons. This stabilises neuronal membranes and limits the rapid, repetitive firing that can spread through the brain during a seizure. Reduced neuronal firing also decreases the release of excitatory neurotransmitters, including glutamate.
The result is less uncontrolled electrical activity. In bipolar disorder, the medicine helps reduce the likelihood of future depressive episodes and other mood episodes, though it is not generally used as the sole treatment for acute mania.
The mechanism is different from that of medicines that mainly enhance gamma-aminobutyric acid activity or directly suppress manic symptoms. The pharmacological action of lamotrigine is described in regulatory prescribing information from the FDA and European Medicines Agency [1].
Common mistakes
Several avoidable errors can reduce benefit or increase risk:
- Restarting the old dose after missing multiple days.
- Increasing the dose faster because seizures or mood symptoms have not improved yet.
- Stopping treatment abruptly after a period of stability.
- Treating a new rash as a minor allergy.
- Forgetting to mention valproate or enzyme-inducing anti-epileptic medicines.
- Driving while experiencing double vision, marked dizziness or poor coordination.
- Assuming that a different tablet strength can be substituted without a titration review.
- Taking extra tablets after a missed dose.
One detail patients often miss is the post-pregnancy change in lamotrigine exposure. A dose that was appropriate late in pregnancy may become excessive after delivery as clearance decreases.
Another practical issue is vomiting or diarrhoea. Repeated gastrointestinal illness can affect regular dosing and hydration, while severe illness can make dizziness and seizure risk harder to interpret.
Comparison
Lamotrigine, sodium valproate and carbamazepine can all be used in epilepsy, but they differ in mechanism, interaction profile and clinical emphasis.
| Treatment approach | Main pharmacological focus | Practical limitation |
|---|---|---|
| Lamotrigine | Sodium-channel modulation and reduced excitatory signalling | Requires gradual titration; rash risk |
| Sodium valproate | Broad anti-seizure activity through several mechanisms | Major reproductive and interaction precautions |
| Carbamazepine | Sodium-channel blockade | Enzyme induction and possible neurological adverse effects |
Lamotrigine is often selected when long-term seizure control or bipolar depressive relapse prevention is a priority. Sodium valproate may be unsuitable for some people who could become pregnant because of significant fetal risk. Carbamazepine can be useful for selected focal seizures, yet its enzyme-inducing effects complicate treatment combinations.
No option is universally best. The seizure type, bipolar history, reproductive plans, liver function, kidney function and current medicines all influence selection.
What doctors say
Clinicians usually judge Lamictal by seizure control, mood stability, functioning and tolerability rather than by a single symptom during the first days. A patient may feel no immediate change while the dose is being increased, because the treatment plan prioritises safe exposure.
A practical prescribing principle is simple: do not accelerate titration because the initial dose feels ineffective. The rash risk is linked to exposure changes, and the correct schedule depends on co-medications.
For bipolar I disorder, doctors generally explain that Lamictal is a maintenance medicine with a stronger role in preventing depressive recurrence than treating acute mania. For epilepsy, the treatment target is fewer seizures without unacceptable dizziness, visual disturbance or coordination problems.
A seizure diary, mood record and list of adverse effects can make appointments more useful. Record the date, time, possible trigger, missed doses and recovery pattern rather than writing only “bad seizure” or “felt unwell.”
Common questions
Is Lamictal suitable for older adults?
Older adults may use Lamictal, but treatment often begins cautiously because age-related kidney or liver changes can affect medicine exposure. The British National Formulary and Medsafe information available in 2025 emphasise review of co-medications, balance, vision and fall risk in older patients. Dizziness, ataxia and blurred vision deserve prompt attention because they can lead to injury. Kidney and liver function may need periodic review during treatment. The prescriber can adjust the regimen when adverse effects or changes in health occur.
What happens when Lamictal is stopped, and does it need tapering?
Stopping Lamictal suddenly can allow seizures to return or worsen, and mood symptoms may recur in people treated for bipolar I disorder. Guidance from the EMA in 2025 supports planned dose reduction when discontinuation is appropriate, except when an urgent reaction requires immediate cessation. The tapering schedule depends on the indication, current dose, duration of treatment and other medicines.
Can people under 18 use Lamictal?
Children and adolescents may receive lamotrigine for selected epilepsy syndromes, including generalised seizures associated with Lennox-Gastaut syndrome. Medsafe paediatric information reviewed in 2025 stresses weight, age, seizure type and co-medications when setting the titration plan. Bipolar disorder use in people under 18 requires specialist assessment because the evidence and regulatory status differ from adult maintenance treatment.
Can Lamictal tablets be split, crushed or chewed?
The handling instructions depend on the specific tablet design and prescribed formulation. The FDA product information in 2025 advises taking lamotrigine as directed and not altering a formulation unless the prescriber or pharmacist confirms that it is suitable. A person who has difficulty swallowing should request an appropriate formulation rather than crushing tablets independently.
Which symptoms mean Lamictal should be stopped and assessed urgently?
A new rash with blisters, peeling skin, mouth or eye sores, facial swelling, fever or swollen glands needs urgent medical assessment because it may indicate a serious hypersensitivity reaction. The EMA safety information in 2025 also identifies breathing difficulty, severe weakness, unusual bruising, jaundice, meningitis-like symptoms and suicidal thoughts as urgent warning signs. Seizures that last unusually long, repeat without recovery or cause breathing problems require emergency services.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Sources
- U.S. Food and Drug Administration (2023). Lamictal (lamotrigine) Prescribing Information.
- European Medicines Agency (2024). Lamotrigine-containing medicinal products: product information.
- U.S. Food and Drug Administration (2023). Lamictal Medication Guide.
Reviews: Lamictal
Hamilton, described better day-to-day stability after a slow titration plan to his prescribed maintenance dose over several weeks. He still experienced occasional blurred vision when another anti-epileptic medicine was adjusted, and the symptom improved after the treatment combination was reviewed. He did not change the dose himself.
Oamaru, said that the first several weeks at the prescribed dose were difficult because of nausea and poor sleep. He stopped taking the tablets without medical advice and later experienced worsening seizure control, so his prescriber restarted treatment cautiously. His experience highlighted the danger of abrupt discontinuation.